Zakup leków kardiologicznych

This tender for cardiovascular medicines is heavily price-driven, making cost leadership the primary success factor. Bidders must meticulously complete all mandatory documentation, particularly the ESPD and Form 2, ensuring accuracy and compliance. While social value and innovation are absent, demonstrating a robust supply chain and commitment to marketing-authorized products will be crucial for differentiation.

Unbeatable Price for Essential Cardiovascular Medicines

Guaranteed Supply of Marketing-Authorized Cardiovascular Treatments

Seamless and Compliant Procurement Process

Achieve the absolute lowest possible price by optimizing sourcing, logistics, and operational costs. Ensure all unit costs in Form 2 are competitive and reflect maximum achievable discounts.

Given the 100% price weighting, the primary focus must be on submitting the most competitive price possible. This requires a deep dive into cost structures, supplier negotiations, and operational efficiencies.

Thoroughly review and complete the European Single Procurement Document (ESPD) and all mandatory forms, paying close attention to details and ensuring all information is accurate and compliant with the tender requirements. Double-check all yellow cells in Form 2.

Clearly state and demonstrate that all proposed cardiovascular medicines possess the necessary marketing authorizations. This is a key eligibility and technical requirement.

Establish a robust internal review process involving multiple stakeholders to check for completeness, accuracy, and compliance of all submitted documents before the deadline.

Ensure that the prices submitted in Form 2 can be fixed for the entire framework agreement period, as required. Understand any potential risks associated with price fluctuations and build in appropriate contingencies if possible without compromising competitiveness.

This tender for cardiovascular system medicines demonstrates good overall quality with clear requirements and a transparent evaluation process, though it lacks explicit sustainability considerations and some minor data points.

The tender exhibits strong legal compliance, utilizing the European Single Procurement Document (ESPD) and clearly defining the procedure type and CPV codes. There are no indications of disputes or suspensions, and the overall structure aligns with national and EU procurement regulations.

The tender description is clear, and requirements are well-documented and understandable, categorized effectively by the AI extraction. Evaluation criteria are explicitly stated as lowest price, which is unambiguous. Performance conditions are referenced to the contract, ensuring clarity upon review of the full documentation.

The tender provides all essential basic information, including title, reference, organization, estimated value, and duration. All specified documents are attached, and requirements and criteria are well-defined within the documentation. The only minor omission is the NUTS code.

This tender scores highly on fairness due to full document access, transparent disclosure of the estimated value, and objective evaluation criteria based solely on the lowest price. The enablement of e-procurement ensures equal access, and the requirements appear generic and not tailored to any specific company.

The tender supports electronic submission and e-procurement, enhancing practicality. The duration of the contract is clearly specified. While the exact contract start date and a single consolidated document URL are not immediately in the basic information, they are implicitly or explicitly available within the full tender documents.

Data consistency is high, with most key fields populated and logical dates for the tender process. There are no reported suspensions or disputes, indicating a stable and consistent tender status. The only minor gap is the unpopulated NUTS code.

The tender does not explicitly incorporate green procurement, social aspects, or innovation focus. This is a common characteristic for procurements of standard medical supplies, but it represents an area for potential improvement in future tenders.